enalapril , a long-acting ace inhibitor , has been demonstrated to improve new york heart association ( nyha ) functional class , pulmonary capillary wedge pressure , cardiac index , maximum oxygen uptake , and exercise tolerance in chf patients .
C0014025
enalapril
C0018802
chf